These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21179937)

  • 21. Superparamagnetic nanoparticles - a tool for early diagnostics.
    Hofmann-Amtenbrink M; Hofmann H; Montet X
    Swiss Med Wkly; 2010; 140():w13081. PubMed ID: 20853192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging concepts in molecular MRI.
    Sosnovik DE; Weissleder R
    Curr Opin Biotechnol; 2007 Feb; 18(1):4-10. PubMed ID: 17126545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent.
    Zhao X; Zhao H; Chen Z; Lan M
    J Nanosci Nanotechnol; 2014 Jan; 14(1):210-20. PubMed ID: 24730260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
    den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
    Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New opportunities, MRI biomarkers in the evaluation of head and neck cancer].
    Gődény M; Léránt G
    Magy Onkol; 2014 Dec; 58(4):269-80. PubMed ID: 25517445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
    Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
    Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.
    Cheng W; Ping Y; Zhang Y; Chuang KH; Liu Y
    J Healthc Eng; 2013; 4(1):23-45. PubMed ID: 23502248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO.
    Li Y; Liu J; Huang JW; Song JC; Ma ZL; Shi HB
    Acta Radiol; 2018 Dec; 59(12):1431-1437. PubMed ID: 29566551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodal nanoparticle imaging agents: design and applications.
    Burke BP; Cawthorne C; Archibald SJ
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymeric nanoparticles for molecular imaging.
    Srikar R; Upendran A; Kannan R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(3):245-67. PubMed ID: 24616442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and molecular imaging with targeted contrast ultrasound.
    Behm CZ; Lindner JR
    Ultrasound Q; 2006 Mar; 22(1):67-72. PubMed ID: 16641795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent development of nanoparticles for molecular imaging.
    Kim J; Lee N; Hyeon T
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance molecular imaging with nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Morawski AM; Schmieder AH; Crowder KC; Wickline SA
    J Nucl Cardiol; 2004; 11(6):733-43. PubMed ID: 15592197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy.
    van Rooij T; Daeichin V; Skachkov I; de Jong N; Kooiman K
    Int J Hyperthermia; 2015 Mar; 31(2):90-106. PubMed ID: 25707815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound contrast agents and ultrasound molecular imaging.
    Wen Q; Wan S; Liu Z; Xu S; Wang H; Yang B
    J Nanosci Nanotechnol; 2014 Jan; 14(1):190-209. PubMed ID: 24730259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance in the era of molecular imaging of cancer.
    Gore JC; Manning HC; Quarles CC; Waddell KW; Yankeelov TE
    Magn Reson Imaging; 2011 Jun; 29(5):587-600. PubMed ID: 21524870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic particle imaging.
    Jakob VB
    Z Med Phys; 2015 Mar; 25(1):1-2. PubMed ID: 25583644
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional MRI using molecular imaging agents.
    Jasanoff A
    Trends Neurosci; 2005 Mar; 28(3):120-6. PubMed ID: 15749164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrostyloid parapharyngeal space tumors: a clinician and imaging perspective.
    Varoquaux A; Fakhry N; Gabriel S; Garcia S; Ferretti A; Chondrogiannis S; Rubello D; Taïeb D
    Eur J Radiol; 2013 May; 82(5):773-82. PubMed ID: 23399040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.